Psychology
Permanent URI for this communityhttp://hdl.handle.net/1903/2270
Browse
3 results
Search Results
Item The Intersecting Effect of Substance Use Stigma, Methadone Treatment Stigma, and Racial Discrimination on Methadone Treatment Outcomes(2024) Kleinman, Mary Buckley; Magidson, Jessica F; Psychology; Digital Repository at the University of Maryland; University of Maryland (College Park, Md.)Methadone treatment (MT) has demonstrated efficacy for treating opioid use disorder (OUD), but adequate engagement in treatment is a persistent challenge. Racially minoritized individuals with OUD disproportionately evidence poor outcomes. Stigma surrounding both substance use disorder (SUD) and MT negatively impact MT engagement. Racially minoritized individuals with OUD also routinely experience race-related stigma. This study aims to evaluate experiences of stigma in a population of patients receiving MT who identify as Black/African American and assess the impact on MT engagement. Participants (N=76) were recruited from an outpatient addiction treatment center in Baltimore City. Self-reported perception of enacted (experience of discrimination from others) and internalized (negative beliefs applied to self) stigma related to MT, SUD, and race were measured using the MT Stigma Mechanism Scale, SU Stigma Mechanism scale, Everyday Discrimination Scale, and an adapted internalized racism scale. Dosing data were collected from medical records over the subsequent 30 days. Correlations between stigma scores were calculated and negative binomial regressions conducted predicting MT engagement by individual stigma measures as well as moderation models looking at the impact of racial stigma on relationship between MT/SUD stigma and MT engagement. All stigma measures were positively correlated with one another. Longitudinal models indicated significant association between higher SU stigma enacted by healthcare providers and lower MT engagement, but no other direct relationships between stigma measures and MT engagement. In moderation models, across all significant moderating effects observed between racial stigma and MT/SU stigma, lower racial stigma appeared to heighten the negative effect of MT/SU stigma on MT engagement. This finding contradicts our original hypothesis based on an expected compounding effect of multiple sources of stigma. Attribution theory, especially related to perceived controllability and blame associated with stigmatized identities, may explain these findings and warrants further exploration in future research within this population. Shame associated with perceived controllability of substance use or need for methadone treatment may cause some patients to engage in avoidance coping strategies, such as disengaging in healthcare or treatment. Better understanding the role of racial identity in this context could help inform integration of intervention strategies to best support MT in the future.Item Psychosocial Syndemics Affecting Treatment Outcomes for Individuals Receiving Medication for Opioid Use Disorder(2020) Kleinman, Mary Buckley; Magidson, Jessica; Psychology; Digital Repository at the University of Maryland; University of Maryland (College Park, Md.)Successful engagement with medication treatment for opioid use disorder (MOUD) is an important focus in the fight against the opioid crisis. This study used qualitative methods to solicit feedback about barriers to successful outcomes in methadone maintenance treatment (MMT) and used these findings to build a conceptual framework of interaction. We recruited patients and staff from a community-based drug treatment center as well as peer recovery coaches who work in OUD recovery. Semi-structured interviews and focus groups asked about factors that influence MMT outcomes and how barriers co-occur and interact. Barriers described by participants fit into several broad themes: individual/self, social, institutional/structural, community/environmental, and stigma. Participants described co-occurrence of barriers as fueling the negative effect of one another. Understanding barriers to successful MOUD outcomes and considering their synergistic effect may assist with future identification and promotion of the types of interventions needed to effectively and efficiently mitigate their impact.Item Psychosocial Syndemics Affecting Treatment Outcomes for Individuals Receiving Medication for Opioid Use Disorder(2020-11) Kleinman, Mary; Magidson, Jessica; Seitz-Brown, CJ; Dougherty, LeaBackground/Objectives: Successful engagement with and retention in medication treatment for opioid use disorder (MOUD) is an important focus in the fight against the opioid crisis. Gaps in opioid use disorder (OUD) care point to a need for improved understanding of factors that affect MOUD outcomes and how barriers may act as syndemic factors, compounding one another’s effects. This study used qualitative methods to solicit feedback about barriers to retention and successful treatment outcomes in methadone maintenance treatment (MMT) and used these findings to build a conceptual framework of interaction. Methods: This study was conducted at a community-based drug treatment center that serves a low-income population, the majority of whom identify as Black or African American. We recruited patients and staff as well as peer recovery coaches who work in OUD recovery across Baltimore City. Semi-structured interviews and focus groups asked about factors that influence MMT treatment outcomes and how barriers co-occur and interact. We used thematic analysis to examine themes pertaining to our research questions and two independent coders coded each transcript based on identified themes. Results: Patient participants (n=20) had a mean age of 48.4 (SD=10.0), 70% male, and 60% Black or African American. Mean reported age of first drug use was 17.7 (SD=5.1). Staff and peer recovery coach (PRC) participants (n=12) had a mean age of 49.2 (SD= 0.7), were 42% male, 75% Black or African American, with an average of 9.6 years working in substance use (SU) treatment. Barriers described by participants fit into several broad themes: individual/self, social, institutional or structural, community or environmental, and stigma. Participants described co-occurrence of these barriers as fueling one another and having a disastrous effect on treatment outcomes. Conclusions: Understanding barriers to successful MOUD (specifically MMT) outcomes experienced by this vulnerable population and considering the synergistic effect of these barriers may assist with identification and promotion of the types of interventions needed to effectively and efficiently mitigate their impact. The conceptual model developed in the analysis of qualitative results for this study can inform future research, including quantitative analysis to build further support for the syndemic relationships presented in the model.